IP Law 360

NOVEMBER 30, 2021

A Delaware federal judge has shot down attempts by several companies, including Natera Inc. and grocery startup Instacart, to invalidate the patent claims they are accused of infringing.

IP 75

IP Patent 75

IP Law 360

JULY 31, 2023

Genetic testing company Natera Inc. has accused a rival lab of ripping off its patented technology for a DNA test to detect and manage cancer, according to a complaint filed in North Carolina federal court.

Technology 40

Technology Patent 40

IP Law 360

AUGUST 9, 2023

Medical testing companies Natera Inc. and Eurofins Viracor LLC told the U.S. Supreme Court Wednesday not to review the invalidation of Stanford University and CareDx patents on a blood test for detecting organ rejection, saying they were correctly found to cover only natural phenomena.

Patent 40

Patent 40

IP Law 360

JUNE 22, 2023

Genetic testing company Natera Inc. waited until competitor ArcherDX sunk millions into similar cancer testing products before filing for patents and suing ArcherDX for infringement, an "unreasonable" and "unexplained" delay that should bar them from enforcing two patents, ArcherDX argued in Delaware federal court Thursday.

Patent 40

Patent 40

IP Law 360

MARCH 15, 2022

million after finding that rival medical test company Natera Inc. A Delaware federal jury on Monday awarded CareDx $44.9 falsely advertised its kidney transplant rejection test as superior to CareDx's competing product, but found that CareDx engaged in false advertising as well.

False Advertising 40

False Advertising Advertising Advertising 40

Fish & Richardson Trademark & Copyright Thoughts

JUNE 15, 2022

Principal Kenneth Darby and Associate Casey Kraning discuss the PTAB’s precedential decision in Sotera Wireless, Inc. In December 2020, the Board designated as precedential Sotera Wireless, Inc. Sotera Wireless, Inc. Fintiv, Inc. Reynolds Vapor Company v. For example, in Cisco Systems, Inc. Apple Inc.

Art 88

Art Journalism IP Litigation 88

43(B)log

JANUARY 21, 2022

Guardant Health, Inc. Natera, Inc., 18, 2022) Guardant sued its competitor Natera over an alleged “campaign of false and misleading advertising directed at” Guardant’s new product Reveal, a liquid biopsy cancer assay for early-stage colorectal cancer (CRC). 2022 WL 162706, No. 21-cv-04062-EMC (N.D.

False Advertising 64

False Advertising Advertising Advertising Journalism 64